LongevityInvestigational

Gerontin (Pineal Gland Extract)

Subcutaneous injection

Overview

Gerontin refers to peptide fractions derived from pineal gland extracts studied primarily in Russian gerontology research. These preparations are hypothesized to contain bioactive peptides that regulate circadian rhythms, antioxidant defenses, and neuroendocrine aging processes.

Mechanism of Action

The pineal gland's role in melatonin synthesis and circadian coordination provides a biological rationale for investigating pineal-derived factors in aging. Gerontin formulations are not standardized, and active components have not been fully characterized by modern analytical methods..

Research Summary & Key Findings

Published studies on gerontin are largely confined to Russian-language literature and report lifespan extension and tumor suppression in rodent models of aging. Peer-reviewed replication in Western journals and rigorous clinical trials are lacking, limiting independent verification of reported effects. The lack of chemical characterization, regulatory approval, and controlled human data leaves gerontin's clinical utility unestablished.

Clinical Status

Investigational

Gerontin (Pineal Gland Extract) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Subcutaneous injection

Related Peptides in Longevity

Find a Provider

Find a verified provider who offers Gerontin (Pineal Gland Extract) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Gerontin (Pineal Gland Extract).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.